Correlation Analysis Between Corneal Biomechanics & Anterior Segment

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Evaluation of the ciliary muscle thickness, area, and anterior chamber angle, as well as anterior sclera thickness in subjects, to investigate the relationship between these measurements and corneal biomechanics. Clarify whether aqueous humor displacement, anterior sclera, and ciliary muscles influence the assessment of in vivo corneal biomechanics.

See also
Status	Clinical Trial	Phase
Completed	`NCT05377099` - Evaluation of the Change in the DA Ratio, IR and SSI as Parameters of Corneal Biomechanics Post Different LVC Procedures	N/A
Completed	`NCT03500523` - Corneal Biomechanical Properties in Pregnancy	N/A
Completed	`NCT03990506` - Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus	N/A

NCT number	NCT06109636
Study type	Observational
Source	Tianjin Eye Hospital
Contact
Status	Completed
Phase
Start date	March 4, 2023
Completion date	October 1, 2023

Correlation Analysis Between Corneal Biomechanics and Anterior Segment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms